Advertisement
Advertisement

LXEO

LXEO logo

Lexeo Therapeutics, Inc. Common Stock

4.89
USD
Sponsored
-0.03
-0.61%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

4.89

0.00
0.00%

LXEO Earnings Reports

Positive Surprise Ratio

LXEO beat 7 of 11 last estimates.

64%

Next Report

Date of Next Report
Aug 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.29
Implied change from Q1 26 (Revenue/ EPS)
--
/
+16.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-51.67%

Lexeo Therapeutics, Inc. Common Stock earnings per share and revenue

On May 11, 2026, LXEO reported earnings of -0.25 USD per share (EPS) for Q1 26, beating the estimate of -0.31 USD, resulting in a 21.78% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.97% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an increase of 16.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Lexeo Therapeutics, Inc. Common Stock reported EPS of -$0.25, beating estimates by 21.78%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.97%, changed from $5.83 before the earnings release to $6.12 the day after.
The next earning report is scheduled for Aug 17, 2026.
Based on -- analysts, Lexeo Therapeutics, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement